USAntibiotics Names Mark Tengler Senior Vice President of Manufacturing Technologies

Audio By Carbonatix

BRISTOL, Tenn.--(BUSINESS WIRE)--Mar 31, 2025--

USAntibiotics, the only U.S. manufacturer of penicillin-based Amoxicillin and Amoxil Clavulanate, the life-saving antibiotics commonly known as Amoxil ® and Augmentin ®, today announced the appointment of Mark Tengler to the position of senior vice president of manufacturing technologies. A seasoned pharmaceutical leader with more than three decades of expertise, Tengler will oversee all aspects of manufacturing at the company’s world-class 394,000-square-foot facility, including antibiotics processing and packaging, plastics processing, engineering, maintenance, building services and warehouse management.

"We are delighted to welcome Mark to the USAntibiotics leadership team," said Patrick Cashman, president, USAntibiotics. "His extensive experience in pharmaceutical manufacturing, regulatory compliance and process innovation align seamlessly with our deep commitment to operational excellence. As we continue to expand operations and strengthen the nation’s domestic supply of life-saving antibiotics, his leadership will be instrumental in advancing our mission and positively impacting millions of Americans."

Tengler brings to his role a proven track record of driving innovation, optimizing complex workflows and leading cross-functional teams to achieve strategic business objectives. His expertise in developing integrated approaches that align facility operations has fueled sustained growth and success across highly competitive markets.

Before joining USAntibiotics, Tengler held executive leadership roles at organizations that include Spectrix Therapeutics, LLC and PharmaFab, LLC. In 2006, he transitioned PharmaFab into Neos Therapeutics, Inc., where he served as founder, president and chief technology officer, and was instrumental in the company’s successful Nasdaq debut.

About USAntibiotics

USAntibiotics is the only U.S. manufacturer of Amoxicillin and Amoxicillin Clavulanate, commonly known as Amoxil ® and Augmentin ®. Based in Bristol, Tennessee, it operates a world-class, 394,000-square-foot antibiotics production facility with the sole focus of making quality, life-saving antibiotics widely available for the benefit of all Americans. USAntibiotics is part of the Jackson Healthcare ® family of companies. For more information, visit www.us-antibiotics.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250331794930/en/

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA TENNESSEE

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: USAntibiotics

Copyright Business Wire 2025.

PUB: 03/31/2025 09:00 AM/DISC: 03/31/2025 09:00 AM

http://www.businesswire.com/news/home/20250331794930/en